1. Pifferi, G., Parravicini, F., Scarpitta, G., and Semeraro, C. (1978): 5th Int. Symp. Med. Chemistry, Brighton, September 4–7. Synthesis and antihypertensive activity of new 6-substituted 3-alkyl- and 3-acyl-hydrazinopyridazines.
2. Parravicini, F., Scarpitta, G., Dorigotti, L., and Pifferi, G. (1979): Farmaco (Sci.), Derivati della 3-idrazinopiridazina. Nota III. Sintesi ed attivita antiipertensiva di nuove 3-(2-acilidrazino)-piridazine-6-alchilamino sostituite.34, 299–310.
3. Carpi, C., Dorigotti, L., and Semeraro, C. (1978): 7th Int. Congress of Pharmacology (IUPHAR), Paris, July 16–21. Pharmacological profile of a new antihypertensive drug: Ethyl-2-[6-[(2-hydroxypropyl)methylamino]-3-pyridazinyl]hydrazinecarboxylate (ISF 2469).
4. Simonotti, L., Zanol, M., Citerio, L., and Pifferi, G. (1980): 7th Int. Symp. on Mass Spectrometry in Biochemistry, Medicine and Environmental Research, Milan, June 16–18. Degradation and metabolic studies on cadralazine, a new antihypertensive agent.
5. Carpi, C., Dorigotti, L., and Semeraro, C. (1980): 3rd Joint Meeting of British and Italian Pharmacological Societies, Verona, June 30-July 1. Cadralazine and its identified metabolites: Comparative effects on blood pressure and on arterial smooth muscle.